BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7688120)

  • 1. Elevated maternal serum alpha-fetoprotein, very low unconjugated oestriol, and very low human chorionic gonadotropin associated with recent fetal death.
    Walters CP; McKinnon WC
    Prenat Diagn; 1993 May; 13(5):423-4. PubMed ID: 7688120
    [No Abstract]   [Full Text] [Related]  

  • 2. Concordant anencephaly in monoamniotic twins and an analysis of maternal serum markers.
    Hansen LM; Donnenfeld AE
    Prenat Diagn; 1997 May; 17(5):471-3. PubMed ID: 9178324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome.
    Yaron Y; Cherry M; Kramer RL; O'Brien JE; Hallak M; Johnson MP; Evans MI
    Am J Obstet Gynecol; 1999 Oct; 181(4):968-74. PubMed ID: 10521763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
    Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
    Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels.
    Cuckle HS; Wald NJ; Densem JW; Royston P; Knight GJ; Haddow JE; Palomaki GE
    Br J Obstet Gynaecol; 1990 Mar; 97(3):272-4. PubMed ID: 1692234
    [No Abstract]   [Full Text] [Related]  

  • 6. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
    Extermann P; Bischof P; Marguerat P; Mermillod B
    Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
    Duric K; Skrablin S; Lesin J; Kalafatic D; Kuvacic I; Suchanek E
    Eur J Obstet Gynecol Reprod Biol; 2003 Sep; 110(1):12-5. PubMed ID: 12932863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-trimester diurnal variation of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol: is it present and does it affect the prediction of a patient's risk for fetal Down syndrome?
    Rose NC; Canick JA; Knight GJ; Pulkkinen A; Tumber MB; Mennuti MT; Palomaki GE
    Prenat Diagn; 1994 Oct; 14(10):947-51. PubMed ID: 7534924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
    Burton BK; Prins GS; Verp MS
    Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum screening.
    Carroll JC
    Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities.
    Crandall BF; Hanson FW; Keener S; Matsumoto M; Miller W
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1864-7; discussion 1867-9. PubMed ID: 7686337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of fetal Turner syndrome with multiple-marker screening.
    Wenstrom KD; Williamson RA; Grant SS
    Am J Obstet Gynecol; 1994 Feb; 170(2):570-3. PubMed ID: 7509569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome.
    Gross SJ; Phillips OP; Shulman LP; Bright NL; Dungan JS; Simpson JL; Elias S
    Prenat Diagn; 1994 Jul; 14(7):609-13. PubMed ID: 7526367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
    Macri JN; Kasturi RV; Krantz DA; Cook EJ
    Obstet Gynecol; 1991 Jun; 77(6):963-5. PubMed ID: 1709482
    [No Abstract]   [Full Text] [Related]  

  • 18. Triple marker screening in native Japanese women.
    Onda T; Kitagawa M; Takeda O; Sago H; Kubonoya K; Iinuma K; Bradley LA; Canick JA; Krasikov NE; Ponting NR; Grier RE
    Prenat Diagn; 1996 Aug; 16(8):713-7. PubMed ID: 8878280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum markers in pregnancies associated with fetal trisomy 21 of native Japanese women with or without fetal morphological abnormalities.
    Hoshi N
    Hokkaido Igaku Zasshi; 2003 Mar; 78(2):139-45. PubMed ID: 12704856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.